- Home
- ACVA vs ENOV Comparison
ACVA vs ENOV Comparison
Compare ACVA & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACVA | ENOV |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ACVA | ENOV |
|---|---|---|
| Price | $8.77 | $24.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $13.96 | ★ $48.13 |
| AVG Volume (30 Days) | ★ 2.2M | 969.8K |
| Earning Date | 02-18-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $735,475,000.00 | ★ $2,233,266,000.00 |
| Revenue This Year | $21.22 | $9.22 |
| Revenue Next Year | $12.27 | $4.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.40 | 11.57 |
| 52 Week Low | $4.95 | $23.58 |
| 52 Week High | $22.47 | $49.38 |
Technical Indicators
Market Signals| Indicator | ACVA | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 35.40 |
| Support Level | $8.61 | $23.58 |
| Resistance Level | $9.07 | $24.94 |
| Average True Range (ATR) | 0.34 | 1.33 |
| MACD | 0.03 | -0.32 |
| Stochastic Oscillator | 74.76 | 7.29 |
Price Performance
Historical ComparisonAbout ACVA ACV Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.